2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session

This episode discussed multiple studies. See the list below for links to articles and relevant content: REVERSE-IT trial data:  https://www.pharmacytimes.com/view/acc-2025-ticagrelor-antidote-restores-platelet-function-treats-bleeding https://evidence.nejm.org/doi/full/10.1056/EVIDoa210004 FAIR-HF2 trial data:  https://www.pharmacytimes.com/view/acc-2025-intravenous-iron-safe-but-results-in-mixed-findings-for-patients-with-heart-failure https://jamanetwork.com/journals/jama/fullarticle/2832132 STRIDE trial data:  https://www.pharmacytimes.com/view/acc-2025-semaglutide-significantly-improves-walking-distance-symptoms-qol-for-individuals-with-pad-and-diabetes https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00509-4/abstract ADVANCE-HTN trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/15/49/advance-htnFRESH-UP trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/17/26/fresh-upFINEARTS-HF trial: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/03/05/17/27/FINEARTS-HF-Analysis